Diffuse Alveolar Hemorrhage Associated with Makyo-kanseki-to Administration

Intern Med. 2016;55(22):3321-3323. doi: 10.2169/internalmedicine.55.6986. Epub 2016 Nov 15.

Abstract

We herein describe the first known case of diffuse alveolar hemorrhage (DAH) associated with the administration of Makyo-kanseki-to, a Chinese herbal drug. A 64-year-old man with bronchial asthma presented with persistent cough. Makyo-kanseki-to was prescribed as an adjunctive treatment for bronchial asthma. Immediately after drug ingestion, the patient expectorated bloody sputum. DAH was diagnosed based on the presence of bilateral ground-glass opacity which was identified on chest computed tomography and bloody bronchoalveolar lavage fluid. We diagnosed that the administration of Makyo-kanseki-to was the responsible medication because the hemorrhage developed immediately after drug ingestion and resolved after the cessation of such medication with no subsequent recurrence.

Publication types

  • Case Reports

MeSH terms

  • Amygdalin / adverse effects*
  • Asthma / drug therapy*
  • Bronchoalveolar Lavage Fluid
  • Drugs, Chinese Herbal / adverse effects*
  • Ephedra / adverse effects*
  • Hemoptysis / chemically induced*
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Alveoli

Substances

  • Drugs, Chinese Herbal
  • makyokansekito
  • Amygdalin